Is it safe to share Afrin (oxymetazoline) nasal spray with another person?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sharing Afrin Nasal Spray Between Individuals

No, one person should absolutely not use another person's Afrin (oxymetazoline) nasal spray—the FDA drug label explicitly warns that "use of this container by more than one person may spread infection," and clinical guidelines consistently recommend against sharing nasal delivery devices to minimize infection transmission risk. 1, 2

Primary Infection Risk

  • The FDA-approved package insert for oxymetazoline directly states that sharing the container spreads infection. 1
  • The European Position Paper on Rhinosinusitis and Nasal Polyps (2020) explicitly advises patients "not to share nasal delivery devices" to minimize infection transmission risk. 2
  • Research demonstrates that nasal spray containers become heavily contaminated with bacteria during use—one study found bacterial growth in 90% of saline nasal spray bottles after just 3 days of use by a single patient, with isolates including Staphylococcus aureus, Pseudomonas aeruginosa, E. coli, and other potentially pathogenic organisms. 3

Mechanism of Contamination

  • Nasal spray bottles become contaminated through direct contact between the spray nozzle and nasal mucosa, as well as from aerosolized droplets during administration. 3
  • The predominant bacterial isolates recovered from used nasal spray containers include normal skin and nasal flora (S. aureus, S. epidermidis, alpha Streptococcus species) as well as gram-negative organisms of potential enteric origin (Pseudomonas, E. coli, Proteus). 3
  • This contamination occurs even with proper technique and represents a significant cross-infection risk when bottles are shared between individuals. 3

Clinical Implications

  • Sharing nasal spray devices can transmit respiratory pathogens, skin flora, and potentially more serious infections between users. 2, 3
  • The risk is particularly concerning during respiratory illness outbreaks or in households where one person has an active infection. 2
  • Even if both individuals are healthy, sharing introduces unnecessary infection risk that is easily avoided by using separate bottles. 1, 2

Practical Recommendation

  • Each person must use their own individual bottle of Afrin nasal spray. 1, 2
  • If cost is a concern, note that oxymetazoline should only be used for ≤3 days anyway to prevent rhinitis medicamentosa (rebound congestion), so a single bottle should not need to be shared. 4, 5, 6
  • For households with multiple people needing nasal decongestant therapy, purchase separate bottles and clearly label them to prevent accidental sharing. 2, 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Preventing Rebound Congestion with Intranasal Corticosteroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Adverse Effects of Long-term Oxymetazoline Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Duration of Use for Oxymetazoline Nasal Spray

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.